Published in Invest Ophthalmol Vis Sci on November 14, 2008
Automated layer segmentation of macular OCT images using dual-scale gradient information. Opt Express (2010) 2.35
Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis. Brain (2011) 2.21
Measurement of local retinal ganglion cell layer thickness in patients with glaucoma using frequency-domain optical coherence tomography. Arch Ophthalmol (2009) 2.18
Retinal ganglion cell layer thickness and local visual field sensitivity in glaucoma. Arch Ophthalmol (2011) 1.85
Reliability of a computer-aided manual procedure for segmenting optical coherence tomography scans. Optom Vis Sci (2011) 1.80
A comparison of visual field sensitivity to photoreceptor thickness in retinitis pigmentosa. Invest Ophthalmol Vis Sci (2010) 1.79
The transition zone between healthy and diseased retina in patients with retinitis pigmentosa. Invest Ophthalmol Vis Sci (2011) 1.73
Rod sensitivity, cone sensitivity, and photoreceptor layer thickness in retinal degenerative diseases. Invest Ophthalmol Vis Sci (2011) 1.47
The inner segment/outer segment border seen on optical coherence tomography is less intense in patients with diminished cone function. Invest Ophthalmol Vis Sci (2011) 1.42
In vivo assessment of retinal neuronal layers in multiple sclerosis with manual and automated optical coherence tomography segmentation techniques. J Neurol (2012) 1.36
Quantitative classification of eyes with and without intermediate age-related macular degeneration using optical coherence tomography. Ophthalmology (2013) 1.35
Evaluation of inner retinal layers in patients with multiple sclerosis or neuromyelitis optica using optical coherence tomography. Ophthalmology (2012) 1.34
Randomized trial of ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for retinitis pigmentosa. Am J Ophthalmol (2013) 1.34
Method for deriving visual field boundaries from OCT scans of patients with retinitis pigmentosa. Biomed Opt Express (2011) 1.31
Long-term characterization of retinal degeneration in rd1 and rd10 mice using spectral domain optical coherence tomography. Invest Ophthalmol Vis Sci (2012) 1.27
Spectral domain optical coherence tomography and adaptive optics: imaging photoreceptor layer morphology to interpret preclinical phenotypes. Adv Exp Med Biol (2010) 1.25
Relationships among multifocal electroretinogram amplitude, visual field sensitivity, and SD-OCT receptor layer thicknesses in patients with retinitis pigmentosa. Invest Ophthalmol Vis Sci (2012) 1.20
Spectral-domain optical coherence tomography measures of outer segment layer progression in patients with X-linked retinitis pigmentosa. JAMA Ophthalmol (2013) 1.20
Transition zones between healthy and diseased retina in choroideremia (CHM) and Stargardt disease (STGD) as compared to retinitis pigmentosa (RP). Invest Ophthalmol Vis Sci (2011) 1.16
First-in-human trial of a novel suprachoroidal retinal prosthesis. PLoS One (2014) 1.16
Evaluation of multimodal imaging in carriers of X-linked retinitis pigmentosa. Exp Eye Res (2013) 1.14
A comparison of multifocal ERG and frequency domain OCT changes in patients with abnormalities of the retina. Doc Ophthalmol (2009) 1.14
Normative reference ranges for the retinal nerve fiber layer, macula, and retinal layer thicknesses in children. Am J Ophthalmol (2012) 1.12
A Comparison of Methods for Tracking Progression in X-Linked Retinitis Pigmentosa Using Frequency Domain OCT. Transl Vis Sci Technol (2013) 1.08
Quantification of peripapillary sparing and macular involvement in Stargardt disease (STGD1). Invest Ophthalmol Vis Sci (2011) 1.07
Automated segmentation of outer retinal layers in macular OCT images of patients with retinitis pigmentosa. Biomed Opt Express (2011) 1.07
Evaluation of inner retinal layers in eyes with temporal hemianopic visual loss from chiasmal compression using optical coherence tomography. Invest Ophthalmol Vis Sci (2014) 1.01
Structural and functional changes associated with normal and abnormal fundus autofluorescence in patients with retinitis pigmentosa. Retina (2012) 0.99
Quantitative fundus autofluorescence and optical coherence tomography in best vitelliform macular dystrophy. Invest Ophthalmol Vis Sci (2014) 0.97
Rates of decline in regions of the visual field defined by frequency-domain optical coherence tomography in patients with RPGR-mediated X-linked retinitis pigmentosa. Ophthalmology (2014) 0.97
Retinal ganglion cell and inner plexiform layer thickness measurements in regions of severe visual field sensitivity loss in patients with glaucoma. Eye (Lond) (2012) 0.95
Relationship between retinal layer thickness and the visual field in early age-related macular degeneration. Invest Ophthalmol Vis Sci (2012) 0.94
Macular atrophy in birdshot retinochoroidopathy: an optical coherence tomography and multifocal electroretinography analysis. Retina (2010) 0.94
Multimodal characterization of proliferative diabetic retinopathy reveals alterations in outer retinal function and structure. Ophthalmology (2015) 0.94
Autofluorescence imaging and spectral-domain optical coherence tomography in incomplete congenital stationary night blindness and comparison with retinitis pigmentosa. Am J Ophthalmol (2011) 0.93
Macular cone abnormalities in retinitis pigmentosa with preserved central vision using adaptive optics scanning laser ophthalmoscopy. PLoS One (2013) 0.93
Phenotypic characterization of 3 families with autosomal dominant retinitis pigmentosa due to mutations in KLHL7. Arch Ophthalmol (2011) 0.92
Retinal single-layer analysis in Parkinsonian syndromes: an optical coherence tomography study. J Neural Transm (Vienna) (2013) 0.91
Longitudinal analysis of the peripapillary retinal nerve fiber layer thinning in patients with retinitis pigmentosa. Eye (Lond) (2013) 0.90
The structure and function of the macula in patients with advanced retinitis pigmentosa. Invest Ophthalmol Vis Sci (2011) 0.90
The external limiting membrane in early-onset Stargardt disease. Invest Ophthalmol Vis Sci (2014) 0.88
A comparison of structural and functional changes in patients screened for hydroxychloroquine retinopathy. Doc Ophthalmol (2014) 0.88
Evaluation of retinal nerve fiber layer thickness in patients with retinitis pigmentosa using spectral-domain optical coherence tomography. Retina (2012) 0.87
Abnormal multifocal ERG findings in patients with normal-appearing retinal anatomy. Doc Ophthalmol (2011) 0.86
TULP1 mutations causing early-onset retinal degeneration: preserved but insensitive macular cones. Invest Ophthalmol Vis Sci (2014) 0.85
A comparison of progressive loss of the ellipsoid zone (EZ) band in autosomal dominant and x-linked retinitis pigmentosa. Invest Ophthalmol Vis Sci (2014) 0.85
Optical coherence tomographic parameters as objective signs for visual acuity in patients with retinitis pigmentosa, future candidates for retinal prostheses. J Artif Organs (2011) 0.84
Optical Coherence Tomography (OCT) Device Independent Intraretinal Layer Segmentation. Transl Vis Sci Technol (2014) 0.84
Fundus-driven perimetry (microperimetry) compared to conventional static automated perimetry: similarities, differences, and clinical applications. Can J Ophthalmol (2013) 0.84
Modeling the flexural rigidity of rod photoreceptors. Biophys J (2013) 0.83
Cone dysfunctions in retinitis pigmentosa with retinal nerve fiber layer thickening. Clin Ophthalmol (2012) 0.82
CrxRdy Cat: A Large Animal Model for CRX-Associated Leber Congenital Amaurosis. Invest Ophthalmol Vis Sci (2016) 0.79
Wide-field retinal optical coherence tomography with wavefront sensorless adaptive optics for enhanced imaging of targeted regions. Biomed Opt Express (2016) 0.77
Sarpogrelate, a 5-HT2A Receptor Antagonist, Protects the Retina From Light-Induced Retinopathy. Invest Ophthalmol Vis Sci (2015) 0.77
Outer Segment Thickness Predicts Visual Field Response to QLT091001 in Patients with RPE65 or LRAT Mutations. Transl Vis Sci Technol (2015) 0.77
Quantification of Ellipsoid Zone Changes in Retinitis Pigmentosa Using en Face Spectral Domain-Optical Coherence Tomography. JAMA Ophthalmol (2016) 0.76
Structure-Function Modeling of Optical Coherence Tomography and Standard Automated Perimetry in the Retina of Patients with Autosomal Dominant Retinitis Pigmentosa. PLoS One (2016) 0.76
Analysis of the Retinal Nerve Fiber Layer in Retinitis Pigmentosa Using Optic Coherence Tomography. J Ophthalmol (2015) 0.75
Structural analysis of retinal photoreceptor ellipsoid zone and postreceptor retinal layer associated with visual acuity in patients with retinitis pigmentosa by ganglion cell analysis combined with OCT imaging. Medicine (Baltimore) (2016) 0.75
Macular Structure and Function in Nonhuman Primate Experimental Glaucoma. Invest Ophthalmol Vis Sci (2016) 0.75
Optical Coherence Tomography Angiography to Estimate Retinal Blood Flow in Eyes with Retinitis Pigmentosa. Sci Rep (2017) 0.75
Histopathological Changes of Inner Retina, Optic Disc, and Optic Nerve in Rabbit with Advanced Retinitis Pigmentosa. Neuroophthalmology (2016) 0.75
Increased aqueous flare is associated with thickening of inner retinal layers in eyes with retinitis pigmentosa. Sci Rep (2016) 0.75
Retinal Neuroprotective Effects of Flibanserin, an FDA-Approved Dual Serotonin Receptor Agonist-Antagonist. PLoS One (2016) 0.75
A novel mutation in the RPE65 gene causing Leber congenital amaurosis and its transcriptional expression in vitro. PLoS One (2014) 0.75
Reliability of a Manual Procedure for Marking the EZ Endpoint Location in Patients with Retinitis Pigmentosa. Transl Vis Sci Technol (2016) 0.75
Optical Coherence Tomography of Retinal Degeneration in Royal College of Surgeons Rats and Its Correlation with Morphology and Electroretinography. PLoS One (2016) 0.75
Longitudinal changes in macular retinal layer thickness in pediatric populations: Myopic vs non-myopic eyes. PLoS One (2017) 0.75
Quantitative Analysis of Retinal Structure using Spectral Domain Optical Coherence Tomography in RPGR-associated Retinopathy. Am J Ophthalmol (2017) 0.75
ACUTE ZONAL OCCULT OUTER RETINOPATHY: Structural and Functional Analysis Across the Transition Zone Between Healthy and Diseased Retina. Retina (2017) 0.75
Optical coherence tomography. Science (1991) 57.87
Quantification of nerve fiber layer thickness in normal and glaucomatous eyes using optical coherence tomography. Arch Ophthalmol (1995) 7.86
Ciliary neurotrophic factor (CNTF) for human retinal degeneration: phase I trial of CNTF delivered by encapsulated cell intraocular implants. Proc Natl Acad Sci U S A (2006) 3.49
Preservation of the inner retina in retinitis pigmentosa. A morphometric analysis. Arch Ophthalmol (1997) 3.12
Morphometric analysis of macular photoreceptors and ganglion cells in retinas with retinitis pigmentosa. Arch Ophthalmol (1992) 2.94
A pilot study of Fourier-domain optical coherence tomography of retinal dystrophy patients. Am J Ophthalmol (2008) 2.78
Methods and perceptual thresholds for short-term electrical stimulation of human retina with microelectrode arrays. Invest Ophthalmol Vis Sci (2003) 2.17
Encapsulated cell-based delivery of CNTF reduces photoreceptor degeneration in animal models of retinitis pigmentosa. Invest Ophthalmol Vis Sci (2002) 1.97
Degenerative changes in a retina affected with autosomal dominant retinitis pigmentosa. Invest Ophthalmol Vis Sci (1989) 1.75
An analysis of normal variations in retinal nerve fiber layer thickness profiles measured with optical coherence tomography. J Glaucoma (2008) 1.54
A comparison of retinal nerve fiber layer (RNFL) thickness obtained with frequency and time domain optical coherence tomography (OCT). Opt Express (2009) 1.39
Retinal nerve fiber layer analysis in RP patients using Fourier-domain OCT. Invest Ophthalmol Vis Sci (2008) 1.37
Retinal nerve fiber layer defects in RP patients. Invest Ophthalmol Vis Sci (2007) 1.36
Activation of retinal ganglion cells in wild-type and rd1 mice through electrical stimulation of the retinal neural network. Vision Res (2008) 1.33
Retinal nerve fiber layer thickness in patients with retinitis pigmentosa. Eye (Lond) (2008) 1.22
Evidence for retinal remodelling in retinitis pigmentosa caused by PDE6B mutation. Br J Ophthalmol (2007) 1.20
Prevalence of disease-causing mutations in families with autosomal dominant retinitis pigmentosa: a screen of known genes in 200 families. Invest Ophthalmol Vis Sci (2006) 2.93
Mutations in the inosine monophosphate dehydrogenase 1 gene (IMPDH1) cause the RP10 form of autosomal dominant retinitis pigmentosa. Hum Mol Genet (2002) 2.26
Mutant prominin 1 found in patients with macular degeneration disrupts photoreceptor disk morphogenesis in mice. J Clin Invest (2008) 2.24
Cutting edge: the PTPN22 allelic variant associated with autoimmunity impairs B cell signaling. J Immunol (2009) 2.21
Measurement of local retinal ganglion cell layer thickness in patients with glaucoma using frequency-domain optical coherence tomography. Arch Ophthalmol (2009) 2.18
Cytoskeletal coherence requires myosin-IIA contractility. J Cell Sci (2010) 2.13
Spectrum and frequency of mutations in IMPDH1 associated with autosomal dominant retinitis pigmentosa and leber congenital amaurosis. Invest Ophthalmol Vis Sci (2006) 1.96
The very large G-protein-coupled receptor VLGR1: a component of the ankle link complex required for the normal development of auditory hair bundles. J Neurosci (2006) 1.93
Retinal ganglion cell layer thickness and local visual field sensitivity in glaucoma. Arch Ophthalmol (2011) 1.85
Genomic rearrangements of the PRPF31 gene account for 2.5% of autosomal dominant retinitis pigmentosa. Invest Ophthalmol Vis Sci (2006) 1.85
A comparison of visual field sensitivity to photoreceptor thickness in retinitis pigmentosa. Invest Ophthalmol Vis Sci (2010) 1.79
The transition zone between healthy and diseased retina in patients with retinitis pigmentosa. Invest Ophthalmol Vis Sci (2011) 1.73
Job satisfaction among hospital nurses revisited: a systematic review. Int J Nurs Stud (2011) 1.67
Next generation sequencing-based molecular diagnosis of retinitis pigmentosa: identification of a novel genotype-phenotype correlation and clinical refinements. Hum Genet (2013) 1.63
Identification of disease-causing mutations in autosomal dominant retinitis pigmentosa (adRP) using next-generation DNA sequencing. Invest Ophthalmol Vis Sci (2011) 1.63
Synthesis, molecular docking and biological evaluation of Schiff base transition metal complexes as potential urease inhibitors. Eur J Med Chem (2010) 1.61
Mutations in the X-linked retinitis pigmentosa genes RPGR and RP2 found in 8.5% of families with a provisional diagnosis of autosomal dominant retinitis pigmentosa. Invest Ophthalmol Vis Sci (2013) 1.60
Targeted high-throughput DNA sequencing for gene discovery in retinitis pigmentosa. Adv Exp Med Biol (2010) 1.58
Quantifying the benefits of additional channels of multifocal VEP recording. Doc Ophthalmol (2002) 1.57
Targeting mycobacterium protein tyrosine phosphatase B for antituberculosis agents. Proc Natl Acad Sci U S A (2010) 1.57
Control of late off-center cone bipolar cell differentiation and visual signaling by the homeobox gene Vsx1. Proc Natl Acad Sci U S A (2004) 1.56
Visual field defects and multifocal visual evoked potentials: evidence of a linear relationship. Arch Ophthalmol (2002) 1.52
Mutations in a BTB-Kelch protein, KLHL7, cause autosomal-dominant retinitis pigmentosa. Am J Hum Genet (2009) 1.52
Mechanotransduction in vivo by repeated talin stretch-relaxation events depends upon vinculin. PLoS Biol (2011) 1.52
Normative ranges and specificity of the multifocal VEP. Doc Ophthalmol (2004) 1.52
Retinal pathology and skin barrier defect in mice carrying a Stargardt disease-3 mutation in elongase of very long chain fatty acids-4. Mol Vis (2007) 1.49
Ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for treatment of geographic atrophy in age-related macular degeneration. Proc Natl Acad Sci U S A (2011) 1.47
The inner segment/outer segment border seen on optical coherence tomography is less intense in patients with diminished cone function. Invest Ophthalmol Vis Sci (2011) 1.42
The Gly56Arg mutation in NR2E3 accounts for 1-2% of autosomal dominant retinitis pigmentosa. Mol Vis (2007) 1.41
GPR179 is required for depolarizing bipolar cell function and is mutated in autosomal-recessive complete congenital stationary night blindness. Am J Hum Genet (2012) 1.33
Method for deriving visual field boundaries from OCT scans of patients with retinitis pigmentosa. Biomed Opt Express (2011) 1.31
Relating retinal nerve fiber thickness to behavioral sensitivity in patients with glaucoma: application of a linear model. J Opt Soc Am A Opt Image Sci Vis (2007) 1.31
The Iroquois homeobox gene, Irx5, is required for retinal cone bipolar cell development. Dev Biol (2005) 1.30
Retinal disease in mice lacking hypoxia-inducible transcription factor-2alpha. Invest Ophthalmol Vis Sci (2005) 1.30
The phenotype of Leber congenital amaurosis in patients with AIPL1 mutations. Arch Ophthalmol (2004) 1.25
Comparing multifocal VEP and standard automated perimetry in high-risk ocular hypertension and early glaucoma. Invest Ophthalmol Vis Sci (2007) 1.24
Highly sensitive determination of microRNA using target-primed and branched rolling-circle amplification. Angew Chem Int Ed Engl (2009) 1.24
A randomized, placebo-controlled clinical trial of docosahexaenoic acid supplementation for X-linked retinitis pigmentosa. Am J Ophthalmol (2004) 1.24
Determining abnormal latencies of multifocal visual evoked potentials: a monocular analysis. Doc Ophthalmol (2004) 1.23
Beta-catenin regulates acetylcholine receptor clustering in muscle cells through interaction with rapsyn. J Neurosci (2007) 1.22
Mutation analysis identifies GUCY2D as the major gene responsible for autosomal dominant progressive cone degeneration. Invest Ophthalmol Vis Sci (2008) 1.21
Detecting glaucomatous damage with multifocal visual evoked potentials: how can a monocular test work? J Glaucoma (2003) 1.20
Relationships among multifocal electroretinogram amplitude, visual field sensitivity, and SD-OCT receptor layer thicknesses in patients with retinitis pigmentosa. Invest Ophthalmol Vis Sci (2012) 1.20
Robust RNAi enhancement via human Argonaute-2 overexpression from plasmids, viral vectors and cell lines. Nucleic Acids Res (2013) 1.20
Spectral-domain optical coherence tomography measures of outer segment layer progression in patients with X-linked retinitis pigmentosa. JAMA Ophthalmol (2013) 1.20
9-Ethyl-3,6-diformyl-9H-carbazole. Acta Crystallogr Sect E Struct Rep Online (2008) 1.18
Epigenetic regulation of retrotransposons within the nucleolus of Drosophila. Mol Cell Biol (2008) 1.18
Quantitative electroretinogram measures of phototransduction in cone and rod photoreceptors: normal aging, progression with disease, and test-retest variability. Arch Ophthalmol (2002) 1.17
Transition zones between healthy and diseased retina in choroideremia (CHM) and Stargardt disease (STGD) as compared to retinitis pigmentosa (RP). Invest Ophthalmol Vis Sci (2011) 1.16
Allelic heterogeneity and genetic modifier loci contribute to clinical variation in males with X-linked retinitis pigmentosa due to RPGR mutations. PLoS One (2011) 1.16
Mutations in the TOPORS gene cause 1% of autosomal dominant retinitis pigmentosa. Mol Vis (2008) 1.15
Visual maturation of term infants fed long-chain polyunsaturated fatty acid-supplemented or control formula for 12 mo. Am J Clin Nutr (2005) 1.13
Normative reference ranges for the retinal nerve fiber layer, macula, and retinal layer thicknesses in children. Am J Ophthalmol (2012) 1.12
A novel GCAP1(N104K) mutation in EF-hand 3 (EF3) linked to autosomal dominant cone dystrophy. Vision Res (2008) 1.12
Variability of full-field electroretinogram responses in subjects without diffuse photoreceptor cell disease. Ophthalmology (2003) 1.10
Trafficking regulation of proteins in Alzheimer's disease. Mol Neurodegener (2014) 1.08
Quantification of peripapillary sparing and macular involvement in Stargardt disease (STGD1). Invest Ophthalmol Vis Sci (2011) 1.07
Transcriptional regulation of APH-1A and increased gamma-secretase cleavage of APP and Notch by HIF-1 and hypoxia. FASEB J (2006) 1.07
Bis{2-[(1H-pyrrol-2-yl)methyl-imino-meth-yl]phenolato-κN,O}zinc(II). Acta Crystallogr Sect E Struct Rep Online (2009) 1.06
Mutations in known genes account for 58% of autosomal dominant retinitis pigmentosa (adRP). Adv Exp Med Biol (2008) 1.05
Determining abnormal interocular latencies of multifocal visual evoked potentials. Doc Ophthalmol (2004) 1.05
Abnormal cone structure in foveal schisis cavities in X-linked retinoschisis from mutations in exon 6 of the RS1 gene. Invest Ophthalmol Vis Sci (2011) 1.05
Skp2 E3 ligase integrates ATM activation and homologous recombination repair by ubiquitinating NBS1. Mol Cell (2012) 1.04
Functional cooperation among Ras, STAT5, and phosphatidylinositol 3-kinase is required for full oncogenic activities of BCR/ABL in K562 cells. J Biol Chem (2002) 1.04
Critical role of monoubiquitination of histone H2AX protein in histone H2AX phosphorylation and DNA damage response. J Biol Chem (2011) 1.04
Effects of intensified conditioning on Epstein-Barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies. J Hematol Oncol (2012) 1.02
Transcriptional regulation of PEN-2, a key component of the gamma-secretase complex, by CREB. Mol Cell Biol (2006) 1.02
Optical coherence tomography measurements of retinal nerve fiber layer thickness in chinese children and teenagers. J Glaucoma (2011) 1.02
Shape discrimination in age-related macular degeneration. Invest Ophthalmol Vis Sci (2002) 1.01
Quercetin reduces obesity-associated ATM infiltration and inflammation in mice: a mechanism including AMPKα1/SIRT1. J Lipid Res (2014) 1.01
Rac1 promotes intestinal epithelial restitution by increasing Ca2+ influx through interaction with phospholipase C-(gamma)1 after wounding. Am J Physiol Cell Physiol (2008) 1.00
Functional characterization of mouse RDH11 as a retinol dehydrogenase involved in dark adaptation in vivo. J Biol Chem (2005) 1.00
Appoptosin is a novel pro-apoptotic protein and mediates cell death in neurodegeneration. J Neurosci (2012) 0.99
Improving glaucoma detection using spatially correspondent clusters of damage and by combining standard automated perimetry and optical coherence tomography. Invest Ophthalmol Vis Sci (2014) 0.99
The role of Skp2 in hematopoietic stem cell quiescence, pool size, and self-renewal. Blood (2011) 0.98
Repeat reliability of the multifocal visual evoked potential in normal and glaucomatous eyes. J Glaucoma (2003) 0.96
Deriving visual field loss based upon OCT of inner retinal thicknesses of the macula. Biomed Opt Express (2011) 0.96
Negative regulation of Stat3 by activating PTPN11 mutants contributes to the pathogenesis of Noonan syndrome and juvenile myelomonocytic leukemia. J Biol Chem (2009) 0.96
Improvement in conduction velocity after optic neuritis measured with the multifocal VEP. Invest Ophthalmol Vis Sci (2007) 0.96
Using ABCG2-molecule-expressing side population cells to identify cancer stem-like cells in a human ovarian cell line. Cell Biol Int (2011) 0.96
Outcome measures and their application in clinical trials for retinal degenerative diseases: outline, review, and perspective. Retina (2005) 0.95
Phenotypic characterization of a large family with RP10 autosomal-dominant retinitis pigmentosa: an Asp226Asn mutation in the IMPDH1 gene. Am J Ophthalmol (2005) 0.95
Cone deactivation kinetics and GRK1/GRK7 expression in enhanced S cone syndrome caused by mutations in NR2E3. Invest Ophthalmol Vis Sci (2003) 0.95
Acute and chronic cadmium toxicity to a saltwater cladoceran Moina monogolica Daday and its relative importance. Ecotoxicology (2008) 0.95
Macular atrophy in birdshot retinochoroidopathy: an optical coherence tomography and multifocal electroretinography analysis. Retina (2010) 0.94
Netrin-1 attracts axons through FAK-dependent mechanotransduction. J Neurosci (2012) 0.94
Comparative annotation of functional regions in the human genome using epigenomic data. Nucleic Acids Res (2013) 0.94
Allopurinol, quercetin and rutin ameliorate renal NLRP3 inflammasome activation and lipid accumulation in fructose-fed rats. Biochem Pharmacol (2012) 0.94
Loss of caveolin-1 impairs retinal function due to disturbance of subretinal microenvironment. J Biol Chem (2012) 0.93
Repeatability of normal multifocal VEP: implications for detecting progression. J Glaucoma (2006) 0.93
Characterization of RP1L1, a highly polymorphic paralog of the retinitis pigmentosa 1 (RP1) gene. Mol Vis (2003) 0.93